Protalix Biotherapeutics Inc (PLX)
SG&A Expense Growth
1.97%
Quarterly · Period ending:
PLX SG&A Expense Growth
Latest reported1.97%period ending
Latest reported1.97%period ending
PLX Quarterly SG&A Growth (QoQ) (0.00% → 1.97%)
Latest values, visible window
High-resolution chart · PNG
PLX sg&a expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 1.9666% | |
| -13.4714% | |
| 20.3824% | |
| 11.6235% | |
| 0.8068% | |
| -13.2044% | |
| 15.5684% | |
| -25.5166% | |
| 11.8459% | |
| -24.8129% | |
| 12.8883% | |
| -8.9556% | |
| 29.4061% | |
| 0.5487% | |
| 8.7781% | |
| 9.077% | |
| -17.2162% | |
| 0% | |
| -100% | |
| -6.8433% | |
| 1.0516% | |
| 6.3368% | |
| 4.794% | |
| 28.35% | |
| -31.1578% | |
| 5.7399% | |
| 16.5056% | |
| 25.0967% | |
| -7.2646% | |
| -38.4318% | |
| 37.301% | |
| 22.2428% | |
| -13.6109% | |
| -25.2767% | |
| 17.8773% | |
| 0.7818% | |
| 10.9184% | |
| -19.2295% | |
| 55.9583% | |
| -8.7035% | |
| 10.5764% | |
| 11.3281% | |
| -20.4969% | |
| 7.7438% | |
| 9.357% | |
| -19.3508% | |
| 17.8926% | |
| 28.4802% | |
| -57.8011% | |
| 59.9569% | |
| 30.3371% | |
| -18.4235% | |
| 3.7565% | |
| 540.8805% | |
| -121.4865% | |
| -36.6438% | |
| 115.1013% | |
| 0.7421% | |
| 5.9633% | |
| -15.1751% | |
| -9.5525% | |
| -22.6371% | |
| 80.9289% | |
| 12.332% | |
| -21.8653% | |
| -50.8948% | |
| 129.7561% | |
| 22.5448% | |
| -5.6406% | |
| -15.2322% | |
| 11.4155% | |
| -34.8214% | |
| 2.0243% | |
| 60.6504% | |
| -38.0665% | |
| -69.4602% | |
| 227.2773% | |
| 1.0682% | |
| 1,571.4844% | |
| 350.4442% | |
| 23.6891% | |
| -19.118% | |
| -27.2649% | |
| 75.5197% | |
| 88.2077% | |
| -66.1663% | |
| -26.8333% | |
| -26.751% | |
| 101.8192% | |
| -44.1032% | |
| 60.8365% | |
| 6.6438% | |
| -10.3904% | |
| -34.2287% | |
| 46.9016% | |
| -3.0237% | |
| -9.2263% | |
| -34.7359% | |
| 6.0863% | |
| -9.8005% |